BioAdaptives, Inc. (BDPT) stock
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
BioAdaptives's enterprise value was $32.99K on Oct 19, 2026, against $300.29K a year earlier. Over the last 5 years it ranged from -$38.78K to $380.43M, with a median of $27.39M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $32.99K | -81.9% |
| 2025 | Dec 31, 2025 | $182.47K | -99.8% |
| 2024 | Dec 31, 2024 | $73.86M | +27.2% |
| 2023 | Dec 29, 2023 | $58.08M | +1175.4% |
| 2022 | Dec 30, 2022 | $4.55M | -91.5% |
| 2021 | Dec 31, 2021 | $53.63M | -23.9% |
| 2020 | Dec 31, 2020 | $70.49M | -82.0% |
| 2019 | Dec 31, 2019 | $391.31M | -8.0% |
| 2018 | Feb 28, 2018 | $425.40M | +2.6% |
| 2017 | Dec 29, 2017 | $414.76M | -7.1% |
| 2016 | Dec 30, 2016 | $446.67M | +79.9% |
| 2015 | Dec 31, 2015 | $248.35M | -70.9% |
| 2014 | Dec 31, 2014 | $852.89M | – |
See a number that looks wrong?